BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Prognosis
9 results:

  • 1. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
    Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
    Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
    Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
    Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. smad3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
    Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
    Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
    Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
    Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
    Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
    Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
    Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
    Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
    Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
    Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.